Clinical Trial Update: Study in Subjects With Light Chain (AL) Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in AL amyloidosis (study terminated; results posted in 2018).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Snippet

Sponsor: Prothena Biosciences Ltd. | Conditions: AL Amyloidosis | Phase 2 | Status: TERMINATED | Results posted: 2018-12-12